Home›Stock Screener›Sai Life Sciences›Quarterly Results

Sai Life Sciences Quarterly Results

Latest Quarter Net Profit
₹98 Cr
QSept 2026
Quarterly Results

Sai Life Sciences quarterly results. In Sept 2026, Sai Life Sciences (SAILIFE) reported revenue ₹663 Cr and net profit ₹98 Cr — revenue +19.9% YoY. For annual financials, live price and key ratios, visit SAILIFE share price screener.

SAILIFE Quarterly Results — Revenue, Profit & EPS Highlights

Sai Life Sciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore SAILIFE share price history to track price trends across different timeframes.

  • Revenue of ₹663 Cr in Sept 2026 (+7.3% vs Mar 2026, +19.9% vs Sept 2025)
  • Net Profit of ₹98 Cr in Sept 2026 (-5.8% vs Mar 2026, +16.7% vs Sept 2025)
  • EBITDA of ₹190 Cr in Sept 2026 (-1.0% vs Mar 2026)
  • Operating Margin of 28.0% in Sept 2026 (-1.0pp vs Mar 2026)
  • Earnings Per Share of ₹4.63 in Sept 2026 (-6.1% vs Mar 2026)

Sai Life Sciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SAILIFE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 663 618 558 553 589 7.3% 19.9%
Net Profit (₹ Cr) 98 104 73 84 88 - -
EBITDA (₹ Cr) 190 192 152 161 167 - -
EPS (₹) 4.63 4.93 3.46 4.01 4.24 - -
Operating Margin (%) 28.0% 29.0% 27.0% 27.0% 27.0% - -

SAILIFE Share Price Trend — 1-Year Movement Across Quarterly Results

Sai Life Sciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View SAILIFE yearly price range for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 14.8%
EBITDA Margin 28.7%
Operating Margin 28.0%
ROE (Annual) 15.8%

Balance Sheet Highlights

Total Assets ₹3,626 Cr
Total Equity ₹2,484 Cr
Current Assets ₹ Cr
Current Liabilities ₹309 Cr

Cash Flow Analysis

Operating Cash Flow ₹509 Cr
Investing Cash Flow ₹-395 Cr
Financing Cash Flow ₹-124 Cr
Net Cash Flow ₹-9 Cr

Current Market Data

Current Price ₹1788.40
Exchange NSE
Last Updated Nov 19, 2026

SAILIFE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Sai Life Sciences latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores